Refining Clinical T-Staging of Oral Tongue Squamous Cell Carcinoma with Structured MRI Reporting to Guide Neoadjuvant Chemoimmunotherapy
Author Block: J. Pan, X. Hui, L-Z. Liu, W. Huang; Guangzhou/CN
Purpose: Current T-staging for oral tongue squamous cell carcinoma (OTSCC) primarily relies on postoperative pathology, which offers suboptimal preoperative risk stratification, limiting precision in the neoadjuvant therapy era. This study aimed to optimize the clinical T-staging for OTSCC using a structured MRI reporting system and evaluate its value in guiding patient selection for neoadjuvant chemoimmunotherapy (NACI).
Methods or Background: In this retrospective study, we analyzed patients with pathologically confirmed OTSCC who underwent pretreatment MRI between January 2010 and January 2025. Based on a structured MRI report, patients were stratified into four risk groups: "Very-low-risk" (no structural invasion), "Low-risk" (hyoglossus/styloglossus invasion), "Medium-risk" (Mild structural invasion: eg., lingual artery, sulcus terminalis, sublingual gland), and "High-risk" (Severe structural invasion: eg., mylohyoid, retromolar trigone, oropharynx). Network and survival analyses were employed to assess prognostic differences. The survival benefit of NACI was specifically evaluated in the high-risk group defined by the new staging system.
Results or Findings: Among 1202 enrolled patients, the optimized T-staging system showed significantly superior risk stratification for 5-year overall survival (OS) (48.1%, 74.8%, 85.9%, 95.1% for the four groups, P <0.001) versus the current T-staging (86.9%, 77.8%, 70.4%, 53.1%, P>0.05). Crucially, high-risk patients receiving NACI had markedly better 5-year OS than those who did not (84.2% vs. 45.9%, p<0.05). The revised T-staging system showed better stratification in OS (C-index: 0.712 vs. 0.652, p < 0.05).
Conclusion: A structured MRI-based T-staging system provides superior prognostic stratification and effectively identifies high-risk OTSCC patients who derive significant survival benefit from NACI, facilitating preoperative personalized treatment planning.
Limitations: This was a retrospective, single-center study. Additionally, there is inherent subjectivity in interpreting structural invasion, although excellent inter-observer agreement was confirmed (kappa > 0.82 for all evaluated structures).
Funding for this study: The National Natural Science Foundation of China (No. 82171906) and the Guangdong Basic and Applied Basic Research Foundation (2025A1515011590, 2024A1515140147).
Has your study been approved by an ethics committee? Yes
Ethics committee - additional information: This retrospective study was conducted in accordance with the ethical guidelines outlined in the 1964 Declaration of Helsinki and approved by the ethics committee (approval number: B2019-047-Y02; date of approval: November 07, 2022).